Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Fuji
AstraZeneca
Colorcon
Cipla
McKesson
Covington
Merck
Express Scripts

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 071298

« Back to Dashboard

NDA 071298 describes BRETYLIUM TOSYLATE, which is a drug marketed by Abraxis Pharm, Astrazeneca, Eurohlth Intl Sarl, Hospira, Intl Medication, Luitpold, West-ward Pharms Int, Abbott, B Braun, Baxter Hlthcare, and Hospira Inc, and is included in fifteen NDAs. Additional details are available on the BRETYLIUM TOSYLATE profile page.

The generic ingredient in BRETYLIUM TOSYLATE is bretylium tosylate. There are three drug master file entries for this compound. Additional details are available on the bretylium tosylate profile page.
Summary for 071298
Tradename:BRETYLIUM TOSYLATE
Applicant:Abraxis Pharm
Ingredient:bretylium tosylate
Patents:0
Medical Subject Heading (MeSH) Categories for 071298

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength100MG/ML
Approval Date:Feb 13, 1987TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Merck
Deloitte
Cerilliant
Colorcon
US Army
Moodys
Johnson and Johnson
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.